Jong Yeon Hwang Selected Research

KRCA-386

5/2016

Minor modifications to ceritinib enhance anti-tumor activity in EML4-ALK positive cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jong Yeon Hwang Research Topics

Disease

5	Neoplasms (Cancer) 11/2017 - 08/2015
2	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 03/2019
2	Hepatitis A (Hepatitis, Infectious) 11/2017 - 05/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2020
1	Brain Neoplasms (Brain Tumor) 05/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2016
1	Stomach Neoplasms (Stomach Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

2	Small Molecule LibrariesIBA 11/2017 - 05/2016
2	EnzymesIBA 11/2017 - 01/2016
2	ceritinibIBA 01/2017 - 05/2016
2	Phosphotransferases (Kinase)IBA 05/2016 - 04/2016
2	CrizotinibIBA 05/2016 - 08/2015
1	Androgen Receptors (Androgen Receptor)IBA 12/2020
1	Proteolysis Targeting ChimeraIBA 12/2020
1	Biological ProductsIBA 12/2020
1	snake venom protein C activatorIBA 12/2020
1	GSK-2816126IBA 09/2020
1	pomalidomideIBA 09/2020
1	(+)-JQ1 compoundIBA 03/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2017
1	KRCA-386IBA 05/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	pyrimidineIBA 01/2016
1	MorpholinosIBA 01/2016
1	1,1'- (4,4'- (((5- chloropyrimidine- 2,4- diyl)bis(azanediyl))bis(3- methoxy- 4,1- phenylene))bis(piperazine- 4,1- diyl))diethanoneIBA 08/2015
1	Proteins (Proteins, Gene)FDA Link 08/2015

Therapy/Procedure

1	Castration 12/2020
1	Immunotherapy 11/2017
1	Therapeutics 04/2016